Mumbai-based startup Veera Health, one of the largest digital therapeutics platforms for managing Polycystic Ovary Syndrome (PCOS), has recently launched a comprehensive test for diagnosing PCOS, in partnership with Tata 1mg.

The diagnosis package is the company’s second major offering for PCOS care while its core product helps navigate PCOS, through a multi-disciplinary approach of medical care, nutrition therapy, lifestyle coaching and doctor support.

Polycystic ovary syndrome (PCOS) is one of the most common lifelong hormonal conditions in women, affecting 1 in 5 Indian women. Lack of awareness and differing sets of criteria for PCOS evaluation makes it difficult to get an accurate diagnosis. Veera Health and 1 mg’s single comprehensive lab test simplifies diagnosis that eliminates the need for PCOS women to consult different specialists to get a conclusive answer.

Designed as an at-home lab test with Tata 1mg, the samples are collected from home and the results are made available in just 48 hours. The reports are available online and also include a 30-minute video consultation with a qualified gynaecologist. Veera offers a similar comprehensive test package for PCOS patients looking to conceive. The test packages start at Rs 2900.

The diagnostic packages are currently available in 24 Indian cities including Agra, Allahabad, Bangalore, Bhubaneswar, Chandigarh, Chennai, Faridabad, Ghaziabad, Gurgaon, Howrah WB, Hyderabad, Jaipur, Kanpur, Kolkata, Lucknow, Meerut, Mumbai, New Delhi, Noida, Patna, Pune, Ranchi, Surat, Varanasi.